SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : North American Vaccine
NVX 1.510-3.8%Oct 31 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Don W Stone who wrote (76)11/20/1996 8:39:00 AM
From: Don W Stone   of 82
 
Money Magazine, Dec 1996, 10 pages on "Vaccination
Dangers"
I finally picked up a copy on the newstands and it is a very moving article.
It is about vaccine "SAFETY", SAFETY, SAFETY, SAFETY.

"HOW TO KEEP YOUR CHILD SAFE"

This is what every one of the Wall Street analyst that follow NVX have been saying is what the new DTaP vaccines are all about.

North American Vaccine from the very beginning set out to develope the safest DTaP vaccine possible and they achieved it. None of there studies have shown any "severe side effects" . This includes the follow up data of some 90,0000 doses administered in Sweden.

The other manufacturers DTaP vaccine trials have not been so successful.They all have shown less severe side effects when compared to the present whole cell DTP vaccines but the data that follows does say that a parent should follow the instructions in the Money Magazine article and "BE INFORMED" Ask to see government "benefit/risk information"

The following clinical trial data was presented to the FDA Vaccine Advisory Commirttee on October 25, 1995.
Connaught: Collapse 29 , Hospitalized 7, Convulsions 4,
Chiron Biocine: Collapse 16, Hospitalized 6, Convulsions 2,
SmithKline: Collapse 22, Hospitalized 7, Convulsions 6,

I will emphasize that North American Vaccine has not experienced any of the above severe side effects.

Now to POLIO. Once again North American Vaccines mission was to develope a SAFER method to protect our children from Polio and to overcome the only real objection to using IPV. Trama of injection.
That is what DTaP-IPV is all about.

Well that is my take on the Money Magazine article.

If you are an NVX stockholder you should be proud of what your company is doing to help address the very concerns brought up in this article.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext